OUR GROUP OF ADVISORS
Dr. Nirupa Bareja
Dr. Nirupa Bareja is a Ph.D. in Biological sciences. She received a CSIR fellowship for her doctoral research, and was also offered the Rhodes Scholarship from the University of Oxford for her post doctoral research. She has several publications in reputed journals.
She is a veteran of the Biocon Group for 15+ years. Her unique skills enabled her to excel at multiple functions in the company, brought her awards and recognitions like “Outstanding Contribution Award” for several years, in multiple areas, helped the company achieve key quality systems accreditations including ISO, FDA, CAP, etc. She has also introduced the HR systems and processes for the company.
After her tenure at Biocon, she decided to contribute to the community in individual capacity.
She currently heads the India operations for Vicus Therapeutics, a US based Biotech company. She also contributes to the area of ‘cancer care’ as the honorary Chief Program Director – Corporate outreach at the Mazumdar Shaw Medical Foundation, Bangalore.
Dr. A. S. Arvind
Dr. A. S. Arvind served as Chief Operating Officer of Clinigene, a subsidiary of Biocon Ltd. from 2000-2010 and was instrumental in planning, initiating and conducting clinical studies, clinical trials, biomarker identification studies, drug development, regulatory compliance both for in house as well as for domestic and multinational pharmaceuticals and biotech companies.
Prior to joining Clinigene, he served as Consultant Physician at West Wales General Hospital, Wales UK between 1996-2000. He served as Medical Director of Mallya Hospital, Bangalore between 1990-1996 and was involved from concept to completion and running of the state-of-the-art tertiary referral hospital. He trained in the UK and India in Internal Medicine and Gastroenterology at St. Bartholomew Hospital and Broadgreen Hospital Liverpool, Victoria, St Martha’s and St John’s Medical College hospitals.
He is also a Senior Advisor to a number of multinational and domestic companies in the healthcare industry.
Debanjan Mukherjee is an engineer, innovator and technologist. He has diverse background in consumer electronics, embedded software and mobile product development. At Apple, he co-invented force sensing multi-touch trackpad with haptic feedback which adds a new dimension to human-computer interaction. He also built the first prototype of Apple pencil. Currently he is an architect at Amazon building new category of internet connected devices like Dash wand and Dash button, which simplify shopping.
Debanjan received MS in electrical and computer engineering from Georgia Institute of Technology and BTech in electronics from Indian Institute of Technology, Kharagpur. He has 30+ US patents and more than a dozen pending. Debanjan is an active angel investor in 10+ technology startups. He enjoys learning new things, mentoring and playing with his kids.
Prof (Dr). Sripada Venkata Joga Rao
Prof (Dr). Sripada Venkata Joga Rao, a Post-Doctoral Research Scholar in Healthcare Law and Ethics is presently anchoring the professional activities of Legalexcel – a Law Firm of Advocates, Solicitors and Healthcare Consultants.
In a teaching career spanning three decades, he has served as founding faculty member in the National Law School of India University. As a Professional Advocate and Solicitor, he provides array of legal services including Litigation, Consultative advise for Hospitals, Doctors, Patient Groups, Health Insurance and TPA entities, Professional Associations of Doctors, Technology Companies, Diagnostic Labs and several technology driven healthcare startups.
In the domain of Healthcare Law and Ethics, his work continues (with an experience of more than two decades) to focus on Medical Negligence Liability of Doctors and Medical Establishments, Surrogacy and ART, Transplantation of Human Organs and Tissues, Clinical Trials and Research, Information Technology and Healthcare, Regulatory and Legal Compliance pertaining to Healthcare Delivery, Medical Tourism, Healthcare Insurance and TPA, End of Life Care apart from others.
He is also associated with couple of Hospitals as Chairperson of their respective Institutional Ethics Committees and Member of Competent Authority.
A prolific author and a seasoned communicator, he has been conferred globally acclaimed and intellectually coveted Max-Planck Fellowship by Max-Planck Institute, Germany.
Dr. Sujay Prasad
Dr.Sujay Prasad is the creative force behind new innovations, technology initiatives and business process improvements at Anand Diagnostic Laboratory. He has been instrumental in expanding the service capability of ADL from facility expansion to acquisition of state of the art equipment. With his zero tolerance attitude to errors, he has designed innovative methods with focus on minimizing errors across all operating processes. He oversees all IT initiatives and has implemented interesting IT enabled ideas such as automated report printing kiosks and online results reporting, much ahead of the industry adoption. He is also a certified lead assessor for NABL accreditation and has conducted technical assessments overseas.
Dr.Sujay Prasad obtained his MD in Pathology from the Mumbai University and joined Anand Diagnostic Laboratory thereafter in 1995.
Dr. Ravi Gaur
Dr. Ravi Gaur, MD Pathology, is a qualified onco-pathologist by profession and has 30 years plus experience in the field of pathology and healthcare management. His core competence has always been in onco-pathology, immunology and evolving technologies. Dr. Gaur is one of the pioneers who have changed the trend of pathology practice in India by introducing many advanced assays and algorithms, equipments and Integrated ICT (Information, Communications, Technology) systems in India.
He is currently the Chief Operating Officer and Lab Director of Oncquest Laboratories, the largest molecular and surgical onco-pathology and final diagnosis provider in India. Under his expert guidance and leadership,
Oncquest Laboratories has become one of the most reputed laboratories in the country with 36 satellite labs and 1500 plus collection centres across India. Oncquest’s R&D unit has done India proud by developing the latest tests in molecular diagnostics which are validated for India’s population and are offered at much lower costs than comparable tests.